ContraFect Corp

NASDAQ:CFRX   3:59:51 PM EDT
3.16
+0.08 (+2.60%)
Earnings Announcements

ContraFect Reports Q3 Loss Per Share $0.13

Published: 11/15/2021 12:47 GMT
ContraFect Corp (CFRX) - Contrafect Reports Third Quarter 2021 Financial Results and Provides Corporate Update.
Q3 Loss per Share $0.13.
Expects to Conduct Planned Interim Futility Analysis to Assess Superiority of Exebacase Versus Soca Alone in First Half of 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.30

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.